Entacapone extends the clinical benefits of L-dopa/DDCI and improves the clinical condition of PD in a range of common L-dopa dosage regimens

被引：0
|
作者：
Beck, SC
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P213
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [1] The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease
    Heikkinen, H
    Nutt, JG
    LeWitt, PA
    Koller, WC
    Gordin, A
    [J]. CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) : 150 - 157
  • [2] Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa dose
    Heikkinen, H
    Varhe, A
    Laine, T
    Puttonen, J
    Kela, M
    Kaakkola, S
    Reinikainen, K
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (04) : 363 - 371
  • [3] CLINICAL EFFECT OF L-DOPA ON SCHIZOPHRENIA
    OGURA, C
    KISHIMOTO, A
    NAKAO, T
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1976, 20 (03): : 308 - 318
  • [4] CLINICAL EFFECTS OF L-DOPA ON EPILEPSY
    INOUE, Y
    IMAZATO, K
    ARIKAWA, K
    INANAGA, K
    MIURA, T
    [J]. FOLIA PSYCHIATRICA ET NEUROLOGICA JAPONICA, 1979, 33 (03): : 307 - 309
  • [5] In vivo assessment of Intrasynaptic dopamine in Parkinson patients following treatment with L-dopa or L-dopa/entacapone
    Seibyl, JP
    Tabamo, R
    Jennings, D
    Tamagnan, G
    Rabinowicz, A
    Marek, K
    [J]. MOVEMENT DISORDERS, 2005, 20 : S44 - S45
  • [6] PRELIMINARY CLINICAL TRIAL WITH L-DOPA IN NARCOLEPSY
    GUNNE, LM
    LIDVALL, HF
    WIDEN, L
    [J]. PSYCHOPHARMACOLOGIA, 1971, 19 (02): : 204 - &
  • [7] METABOLISM AND CLINICAL ASSESSMENT OF L-DOPA IN PARKINSONISM
    ERICSSON, AD
    MCCANN, D
    SHARPLESS, N
    REVENO, W
    [J]. NEUROLOGY, 1970, 20 (04) : 402 - +
  • [8] OBSERVATIONS ON RANGE OF EFFICACY OF L-DOPA
    KLAWANS, HL
    [J]. CONFINIA NEUROLOGICA, 1971, 33 (03): : 133 - +
  • [9] Temporal administration of entacapone with slow release L-dopa: pharmacokinetic profile and clinical outcome
    Brusa, L
    Pierantozzi, M
    Bassi, A
    Fedele, E
    Lunardi, G
    Giacomini, P
    Stanzione, P
    [J]. NEUROLOGICAL SCIENCES, 2004, 25 (02) : 53 - 56
  • [10] Temporal administration of entacapone with slow release L-dopa: pharmacokinetic profile and clinical outcome
    L. Brusa
    M. Pierantozzi
    A. Bassi
    E. Fedele
    G. Lunardi
    P. Giacomini
    P. Stanzione
    [J]. Neurological Sciences, 2004, 25 : 53 - 56
12345